Publication & Citation Trends
Publications
0 total
1555P Keynote-G08: An open-label, multicenter, dose escalation and expansion phase I/II study of GI-102 (CD80/IL2v3) in advanced solid tumors (part A and D of GII-102-P101)
Cited by 0
Semantic Scholar
580 Phase 1 study of mitotic checkpoint inhibitor BAL0891 in combination with tislelizumab (anti-PD-1 antibody) in patients with advanced solid tumors
Cited by 0
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(294)
HER2/EGFR in Cancer Research
(284)
Breast Cancer Treatment Studies
(193)
Cancer Treatment and Pharmacology
(168)
PARP inhibition in cancer therapy
(110)
Affiliations
AstraZeneca (United Kingdom)
Ulsan College
University of Southern California
Roche (Switzerland)
Seoul National University of Science and Technology